PHYTOMAB

Owners

Goods & Services

[ pharmaceutical research and development; ] chemistry services, namely, chemical analysis; synthetic biology services, namely, research and analysis in the field of synthetic biology; stem cells biology services, namely, research and analysis in the field of stem cell biology; Stem cell research services; drug discovery services using plant cells; drug discovery services using stem cells; development services of new pharmaceutical products; [ laboratory research services relating to pharmaceuticals; ] testing of pharmaceuticals; medical research; biotechnological research; biological research; chemical research; research and development services relating to genetic testing; research and development services relating to medical, pharmacological and veterinary science; laboratory research in the field of pharmaceuticals, biology, biochemistry and chemistry; research and development services in the field of [ microorganisms and ] cells technology; research services in the field of chemistry, biochemistry, enzymology, biology, cell biology and biotechnology

Medicines for the treatment of cancer, namely, anticancer medicines; biological preparations for medical, pharmaceutical and veterinary purposes, namely, biological preparations for treatment of cancer; proteins for medical, pharmaceutical and veterinary purposes, namely, protein arrays for medical diagnosis purposes; biological vectors for medical, pharmaceutical and veterinary purposes, namely, viral vectors for treatment of cancer; [ preparations of transformation microorganisms for medical, pharmaceutical and veterinary purposes, namely, for the treatment of cancer; preparations of microorganisms for medical, pharmaceutical and veterinary purposes used for enhancing biomolecule production for treating cancer; ] preparations of gene recombination for medical, pharmaceutical and veterinary purposes used for biomolecule production for treating cancer; recombinant cells for medical, pharmaceutical and veterinary purposes; cell lines for medical, pharmaceutical and veterinary purposes; medical, pharmaceutical and veterinary preparations for the treatment of cells; stem cells for medical, pharmaceutical and veterinary purposes; vaccines for medical, pharmaceutical and veterinary purposes; antibiotics for medical, pharmaceutical and veterinary purposes; anti-cancer preparations for medical, pharmaceutical and veterinary purposes; nucleic acid sequences for medical, pharmaceutical and veterinary purposes; biopharmaceuticals for treatment of hepatitis; biopharmaceuticals for the treatment of cancer; biopharmaceuticals for the treatment of auto-immune diseases